Attana has published the company presentation given on Biotech Showcase™ 2021

The conference this year took place in digital form between January 11 to January 15. During the conference Attana broadcasted a 25-minute presentation, which is now published on Attana’s website and Youtube channel. In addition to the presentation, Attana had several rewarding meetings with potential customers that the company will follow up on.

The recorded presentation can be found here

For more information, please contact:

Teodor Aastrup, CEO Attana AB 
+ 46 8 674 57 00

The Board of directors for Attana consider that the information in this press release is not likely to have a significant effect on the share price but is of general interest for the shareholders and hence should be communicated.

About Attana

Attana was founded in 2002 with the vision of in vitro characterization of molecular interactions mimicking in vivo conditions. Since then, Attana has developed proprietary label free biosensors for biochemical, crude, sera, and cell-based assays and the Attana Virus Analytics (AVA) platform, a proprietary in vitro diagnostics (IVD) tool. Attana products and research services are used by Big Pharma, biotech companies and academic institutions within the life sciences. To learn more about our latest services and products, please visit or contact